Bernama.com, 7 Jan 2009, Zakaria Abdul Wahab
SINGAPORE, Jan 7 (Bernama) -- A Singapore consortium dealing in immunology research has joined hands with a French bio-pharmaceutical company in developing antibody-based therapies that could be used for specific viral diseases prevalent in Asia.
The Singapore Immunology Network (SIgN), a research consortium under the republic's Agency of Science, Technology and Research (A*STAR) said today it would collaborate with the French company, Humalys SAS, to speed up the development of the antibody-based therapies.
Read More
Related News:
Singapore, France to collaborate in developing antibody-based therapies - Mathaba News Agency, 7 Jan 2009
